|
Shishkova V.N., Shishkov V.A.
Neurorehabilitation after a stroke: What a therapist should know
|
№10 / 2023
|
|
Grigorieva V.N., Nesterova V.N., Ruina E.A., Sivograk A.A., Averina E.V.
Phenotypical variability of cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL): Description of three cases in one family
|
№5 / 2023
|
|
Kabysh S.S., Prokopenko S.V., Abdullayev M.B.
Cognitive disorders in patients during the acute period of coronavirus infection complicated by pneumonia and during the acute period of ischemic stroke: Similarities and differences
|
№5 / 2023
|
|
Belyaeva I.A., Pyokhova Ya.G., Vershinin A.A.
Stress and its influence at the cardiovascular system
|
№9 / 2022
|
|
Sergeeva S.P., Savin A.A., Litvitskiy P.F., Savin L.A., Manasova Z.Sh., Dzhumagulova D.D., Breslavich I.D.
The role of apoptosis-regulating ligand-receptor Fas and TNF-α systems ratios in the ischemic stroke clinical manifestations formation
|
№9 / 2022
|
|
Zakharov V.V., Gromova D.O.
Neurological manifestations of post-covid syndrome
|
№1 / 2022
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Rayimzhanov Z.R., Redjapova N.A., Yusupov F.A.
Braking progression of nephro- and cerebrovascular complications during atrial fibrillation: opportunities of rivaroxaban
|
№1 / 2020
|
|
I.S. Yavelov
Directly acting oral anticoagulants in the stroke prevention in patients with non-valvular atrial fibrillation and different concomitant diseases
|
№2 / 2017
|
|
M.A. Domashenko, D.V. Sergeev
Efficiency of citicoline in the therapy of cognitive and motor disorders in patients in the early recovery period of stroke
|
№5 / 2016
|
|
V.V. Cheltsov, Yu.Sh. Gushina, T.S. Illarioniva, E.А. Korovyakova, A.E. Moiseeva, A.P. Pereversev, Ye.Yu. Stefanenko, S.K. Ziryanov
Angiotensin II receptor blockers: focus on cardesartan
|
№4 / 2016
|
Русский
